HTFL vs HYPR
HTFL: HeartFlow uses AI-powered software to transform standard cardiac scans into actionable 3D insights for non-invasive coronary artery disease diagnosis and treatment planning. HYPR: Hyperfine makes AI-powered portable ultra-low-field MRI systems designed to bring affordable brain imaging to hospitals and clinics anywhere, without specialized facilities or technicians.
Side-by-side fundamentals
| Metric | HTFL | HYPR | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $24.23 | $0.98 | |
| Market cap as of 2026-07-23 | $2.2B | $100M | |
| Net margin as of 2026-07-23 | -58.4% | -226.9% | HTFL higher |
| Gross margin as of 2026-07-23 | +78.1% | +51.2% | HTFL higher |
| Operating margin as of 2026-07-23 | -43.1% | -226.6% | HTFL higher |
| ROE as of 2026-07-23 | -38.9% | -101.3% | HTFL higher |
| ROA as of 2026-07-23 | -36.4% | -68.8% | HTFL higher |
| Debt / equity as of 2026-07-23 | 0.00 | 0.38 | HTFL lower |
| Revenue growth (YoY) as of 2026-07-23 | +41.3% | +30.7% | HTFL higher |
| Revenue CAGR (3y) SEC XBRL | +42.1% | +25.8% | HTFL higher |
| Beta as of 2026-07-23 | 1.99 | 1.43 | |
| 1-year return as of 2026-07-22 close | -12.7% | +2.3% | HYPR higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.